When you hit the wall with your insurance provider, you start asking uncomfortable questions. My frustration with Molina Healthcare—specifically, coverage denials for treatments my doctor recommended and billing surprises that arrived months after service—forced me to confront a basic truth: the American health insurance system isn’t the only way to organize healthcare. Looking at Portugal’s universal system wasn’t academic; it was personal. I wanted to understand what a functional, simpler healthcare system actually looks like when you can’t get basic coverage approved without fighting.
Molina Healthcare operates in 18 states and serves over 5 million members, primarily through Medicaid and exchange plans. When I encountered a situation where a specialist referral required prior authorization that took six weeks to process, during which time the condition worsened, I realized the problem wasn’t just my plan—it was the entire incentive structure. Portugal spends 9% of GDP on healthcare compared to America’s 17%, covers 100% of its population, and has no insurance denials for medically necessary care. That gap made me ask: what are we actually paying for?.
Table of Contents
- Why Does Molina’s Prior Authorization Requirement Drive People Toward Overseas Comparisons?
- How Does America’s Insurance Model Create Hidden Costs That Portugal Avoids?
- What Does Molina’s Existence Say About How American Policymakers View Healthcare?
- What Could American Policymakers Learn from Portugal’s Approach?
- Why Does the U.S. System Resist Adopting Universal Healthcare Despite Its Costs?
- What Specific Molina Policies Exemplify These Broader System Problems?
- Where Does American Healthcare Policy Head as Healthcare Costs Keep Rising?
- Conclusion
Why Does Molina’s Prior Authorization Requirement Drive People Toward Overseas Comparisons?
Molina, like most U.S. insurers, uses prior authorization as a gatekeeper mechanism—requiring doctors to prove a treatment is necessary before coverage kicks in. This creates a two-level system: those with time, medical literacy, and access to advocates navigate it; everyone else gets delayed care or goes without. I watched my physician spend 45 minutes on hold with Molina’s authorization line while a patient waited, unpaid clinic time that gets absorbed by the practice and ultimately discourages providers from serving Molina plans. Portugal’s system eliminates this layer entirely.
Once you’re registered with a public health center, referrals to specialists are approved in the system—no insurance company reviewing medical decisions. The trade-off is longer wait times for non-urgent procedures (a hip replacement might be scheduled six months out), but emergency and urgent care move fast. When you’re dealing with something like diabetes management or high blood pressure, you don’t get coverage denials; you get treated. For Molina members, the practical reality is that authorization denials aren’t rare. National data shows that about 1 in 200 prior authorization requests get denied outright, but another chunk are approved with delays that matter clinically. The psychological cost is real: you can’t schedule a procedure; you can’t plan; you have to call back repeatedly.
How Does America’s Insurance Model Create Hidden Costs That Portugal Avoids?
The Molina experience illuminates why the U.S. system costs more for worse outcomes. Every member interaction involves billing codes, deductibles, out-of-pocket maximums, and the byzantine appeals process. I discovered that two identical office visits showed up differently in Molina’s system depending on whether the provider coded it as preventive or diagnostic—a difference that affected my out-of-pocket cost by $75. Portugal’s healthcare system has no such surprises. You pay a fixed percentage of income as a social contribution, and then most healthcare is free at point of service. A doctor visit costs nothing; an urgent care visit costs nothing; a specialist visit costs nothing.
A medication might have a small copay (roughly $5-10 in USD equivalent). There’s no surprise bill arriving six months later. There’s no network to navigate. The government sets drug prices negotiating with manufacturers directly, which is why medications cost 40-60% less than in the United States. The limitation of Portugal’s system worth noting: if you want private care to skip public sector wait times, you pay out of pocket entirely. There’s no hybrid model like we have with supplemental insurance. And the public system is stretched thin in some areas—psychiatric services, in particular, have years-long waiting lists. So while Portugal solves the “surprise bill” and “coverage denial” problems, it trades them for limited choice and wait times.
What Does Molina’s Existence Say About How American Policymakers View Healthcare?
Molina Healthcare exists because the U.S. system is designed to privatize profit and socialize risk. Medicaid—the program Molina primarily serves—is state-run but heavily contracted to private insurers who take a cut. Molina’s business model is to enroll high-volume, lower-income patients and manage costs through aggressive prior authorization, narrow networks, and payment delays. The company made $8.5 billion in revenue in 2023 while paying executives handsomely. None of that revenue goes to care; it goes to shareholder returns and administrative overhead. In Portugal, there is no Molina equivalent.
The government directly employs or contracts with healthcare providers. There’s no middle insurance layer extracting profit. This isn’t ideological—it’s what universal systems do by definition. The money spent on healthcare goes to healthcare: staffing, facilities, medications, salaries. Administrative costs in Portugal’s system run about 2% of total spending. In the U.S., administrative costs—billing, collections, insurance company overhead—represent 8% of healthcare spending. That’s roughly $100 billion annually that doesn’t touch a patient. The warning here is direct: if you rely on a private insurer like Molina, you are accepting that a for-profit corporation will make coverage decisions on your behalf, and those decisions will be weighted toward protecting the company’s margins, not your health.
What Could American Policymakers Learn from Portugal’s Approach?
Portugal’s system demonstrates that you can cover everyone, reduce costs, and maintain quality care without private insurance gatekeepers. In 2023, Portugal ranked 12th globally in life expectancy, ahead of the United States, which ranked 46th. Maternal mortality in Portugal is 7 per 100,000 live births; in the U.S., it’s 32 per 100,000—a staggering difference for a wealthy nation. The practical lesson isn’t that America should copy Portugal exactly. Portugal is 87% ethnically Portuguese with 10 million people and different demographics and disease burdens than the U.S.
But the principle translates: removing the insurance company from the approval process eliminates a conflict of interest and reduces administrative waste. Germany, which kept a multipayer private insurance system, still achieved universal coverage by regulating prices and eliminating medical bankruptcies—something America hasn’t done. For Molina members specifically, the tradeoff of a policy change like this is real. If the U.S. moved toward a public system, Molina as a company would either transform into a public administrator (like some managed-care organizations already do) or cease to exist. But that restructuring is the point: we’re paying premium prices for coverage that behaves more like a barrier than a benefit.
Why Does the U.S. System Resist Adopting Universal Healthcare Despite Its Costs?
The political barrier is substantial. Molina and other insurers spend millions on lobbying and campaign contributions to block healthcare reform. The American Medical Association, which you’d think would prefer not spending staff time on insurance authorization, benefits from the high-price system and lobbies against cost controls. There’s an entrenched coalition of hospital systems, pharmaceutical companies, device manufacturers, and insurers all extracting value from complexity. Additionally, many Americans believe the existing system offers better choice and innovation—a belief not entirely supported by evidence. Americans do get faster access to some advanced procedures, but we also have longer waits for preventive care, dental care, and mental health services.
Innovation in drug development is real, but it’s also driven by government-funded NIH research; the claim that we need private insurance companies to fund innovation doesn’t hold up statistically. The limitation worth understanding: moving from Molina to a public system would require either a tax increase to fund healthcare universally or a massive reallocation of where current healthcare dollars go. That’s a genuine policy choice, not a technical one. Portugal pays roughly 25% of income in combined social contributions, higher than U.S. payroll taxes, though citizens receive healthcare, education, and childcare subsidies in return. The trade is real, even if the outcome is better health.
What Specific Molina Policies Exemplify These Broader System Problems?
Molina’s narrow networks—where you can only see in-network providers or pay much more—are standard industry practice but particularly limiting on Medicaid plans. If you move or your doctor leaves the network, you might lose continuity of care. I had a primary care physician leave Molina’s network; transferring records and finding a new doctor took three months. Meanwhile, I was paying the same premium and still couldn’t get timely care.
The billing and collection practices amplify this. Molina processes millions of claims weekly through automated systems that frequently misclassify or deny claims for administrative reasons (wrong code, missing documentation), forcing patients or providers to appeal. A single appeal can take 30-60 days. Portugal’s system has no such administrative friction. Your public health center has your full medical history and ongoing relationship.
Where Does American Healthcare Policy Head as Healthcare Costs Keep Rising?
The trajectory suggests continued fragmentation unless policy shifts. Costs are rising faster than wages, employers are dropping coverage, and the political pressure for change is building. Some states have explored public option plans, where the government would be an insurance option alongside private plans like Molina. Massachusetts and Oregon have considered this; Rhode Island has discussed it.
The public option theory is that competition with a government plan would force insurers to improve service and lower costs. The realistic outlook is that insurance companies will likely consolidate further, consolidating power, while the uninsured and underinsured population grows. Molina and others will lobby to prevent public options and price regulation. Without intervention, the bifurcation between people with good employer coverage and everyone else will deepen. The Portugal comparison becomes a thought experiment rather than an immediate policy lesson—not because their system is flawed, but because American politics makes change expensive and slow.
Conclusion
My frustration with Molina Healthcare was the catalyst for understanding that the insurance-based model isn’t inevitable or even optimal. It’s a choice—one that serves insurance companies, not patients.
Portugal isn’t a perfect system, but it demonstrates that you can organize healthcare to prioritize care over profit, reduce administrative waste, and cover everyone without the denials, surprises, and gatekeeping that define the American experience. The question isn’t whether universal healthcare works; other countries have proven it does. The question is whether American policymakers will address the structural problems that Molina exemplifies—or whether they’ll continue protecting insurance industry profits while costs rise and outcomes stagnate.